Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine

被引:74
作者
Chan, WK [1 ]
Nguyen, LT
Miller, VP
Harris, RZ
机构
[1] Univ Pacific, Sch Pharm, Dept Pharmaceut & Med Chem, Stockton, CA 95758 USA
[2] GENTEST Corp, Woburn, MA 01801 USA
[3] SmithKline Beecham Pharmaceut, Drug Metab & Pharmacokinet, King Of Prussia, PA 19406 USA
关键词
cytochrome P-450 3A4; grapefruit juice; red wine; mechanism of inhibition;
D O I
10.1016/S0024-3205(98)00013-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Grapefruit juice is well documented to cause clinically significant increases in the plasma concentrations of many therapeutic agents. These interactions are believed to be mediated via inhibition of intestinal cytochrome P-450 3A4 (CYP3A4) by flavonoids and/or other chemicals in grapefruit juice, although the mechanism of that inhibition has not been fully characterized. Like grapefruit juice, red wine contains large amounts of flavonoids and other xenobiotics which could also mediate CYP3A4 inhibition. In this study, we investigated the mechanism of inhibition of CYP3A4 by grapefruit juice and also examined the ability of red wine to inhibit this enzyme. Both red wine and grapefruit juice potently inhibited CYP3A4 activity in a concentration-dependent manner. At 8% of natural strength, enzyme activity was inhibited almost 90 and 84%, respectively, by grapefruit juice and red wine. In contrast, white wine did not appreciably inhibit Grapefruit juice irreversibly inactivated CYP3A4 in a time-and NADPH-dependent manner. The rate of inactivation mediated by grapefruit juice was similar to that mediated by troleandomycin, a potent mechanism-based inhibitor of CYP3A4. Red wine also inactivated CYP3A4 but at a rate approximately 16% that of grapefruit juice. Inhibition of CYP3A4 by red wine is primarily reversible in nature. The clinical implications of this research are discussed. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:PL135 / PL142
页数:8
相关论文
共 23 条
[1]   INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE [J].
BAILEY, DG ;
SPENCE, JD ;
MUNOZ, C ;
ARNOLD, JMO .
LANCET, 1991, 337 (8736) :268-269
[2]   Grapefruit juice alters terfenadine pharmacokinetics resulting in prolongation of repolarization on the electrocardiogram [J].
Benton, RE ;
Honig, PK ;
Zamani, K ;
Cantilena, LR ;
Woosley, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (04) :383-388
[3]  
BUENING MK, 1981, CANCER RES, V41, P67
[4]   DEGRADATION OF RAT-LIVER CYTOCHROMES-P450 3A AFTER THEIR INACTIVATION BY 3,5-DICARBETHOXY-2,6-DIMETHYL-4-ETHYL-1,4-DIHYDROPYRIDINE - CHARACTERIZATION OF THE PROTEOLYTIC SYSTEM [J].
CORREIA, MA ;
DAVOLL, SH ;
WRIGHTON, SA ;
THOMAS, PE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 297 (02) :228-238
[5]   TROUGH CONCENTRATIONS OF CYCLOSPORINE IN BLOOD FOLLOWING ADMINISTRATION WITH GRAPEFRUIT JUICE [J].
DUCHARME, MP ;
PROVENZANO, R ;
DEHOORNESMITH, M ;
EDWARDS, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (05) :457-459
[6]   DISPOSITION OF INTRAVENOUS AND ORAL CYCLOSPORINE AFTER ADMINISTRATION WITH GRAPEFRUIT JUICE [J].
DUCHARME, MP ;
WARBASSE, LH ;
EDWARDS, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (05) :485-491
[7]  
EDGAR B, 1992, EUR J CLIN PHARMACOL, V42, P313
[8]   Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice [J].
Edwards, DJ ;
Bernier, SM .
LIFE SCIENCES, 1996, 59 (13) :1025-1030
[9]  
Edwards DJ, 1996, DRUG METAB DISPOS, V24, P1287
[10]  
Fukuda K, 1997, BIOL PHARM BULL, V20, P560, DOI 10.1248/bpb.20.560